IDH1 and neoplasm: Using AGI-5198, Rohle and colleagues demonstrated that mutant IDH1 inhibition blocked production of D-2HG by the mutant enzyme in a dose-dependent manner, and inhibited tumor growth in mouse xenografts and promoted cell differentiation in glioma cells [38].